Lundblad Roger L, White Gilbert C
Department of Pathology, University of North Carolina, Chapel Hill, NC 27516-6695, USA.
Platelets. 2005 Nov;16(7):373-85. doi: 10.1080/09537100500123568.
Thrombin is a potent agonist of platelets. In the current article, the research on the interaction of thrombin with blood platelets is reviewed starting with the first studies demonstrating the direct action of thrombin on platelets and ending with an analysis of the importance of the protease-activated receptors (PARs) and the GpIb complex. The antithrombin activity of platelets is discussed in terms of the binding of thrombin to receptor(s) on the platelet surface. Evaluation of the PAR receptors and the GpIb supports a model where thrombin binds to the GpIb receptor prior to the proteolysis of the PAR receptor(s). Thus, the maximal hemostatic response requires both PAR receptors and the GpIb receptors.
凝血酶是血小板的一种强效激动剂。在本文中,我们回顾了关于凝血酶与血小板相互作用的研究,从最初证明凝血酶对血小板有直接作用的研究开始,一直到对蛋白酶激活受体(PARs)和糖蛋白Ib(GpIb)复合物重要性的分析。根据凝血酶与血小板表面受体的结合情况讨论了血小板的抗凝血酶活性。对PAR受体和GpIb的评估支持了一种模型,即凝血酶在PAR受体蛋白水解之前先与GpIb受体结合。因此,最大的止血反应需要PAR受体和GpIb受体两者。